Kering SA (OTCMKTS:PPRUY – Get Free Report) saw a large growth in short interest in June. As of June 30th, there was short interest totaling 189,301 shares, a growth of 191.9% from the June 15th total of 64,854 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 1,721,041 shares, the short-interest ratio is currently 0.1 days.
Wall Street Analyst Weigh In
Several brokerages recently commented on PPRUY. HSBC cut shares of Kering from a “buy” rating to a “hold” rating in a research note on Tuesday, April 21st. TD Cowen reiterated a “buy” rating on shares of Kering in a research note on Thursday, April 9th. Barclays raised Kering from a “strong sell” rating to a “hold” rating in a report on Monday, May 11th. Finally, Zacks Research raised Kering from a “strong sell” rating to a “hold” rating in a research report on Monday, May 25th. Two analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Kering currently has a consensus rating of “Hold”.
Check Out Our Latest Stock Analysis on PPRUY
Kering Trading Down 0.5%
Kering Company Profile
Kering is a global luxury goods group headquartered in Paris that designs, produces and distributes high-end fashion, leather goods, jewelry and watches. The company owns and manages a portfolio of well-known maisons — including Gucci, Saint Laurent, Bottega Veneta, Balenciaga, Alexander McQueen and several specialist jewelry and watchmakers — and supports those brands with centralized services for sourcing, manufacturing oversight, distribution and retail operations.
Originally part of a broader retail conglomerate, the group repositioned itself over the past two decades as a focused luxury house and adopted the Kering name in the 2010s.
Further Reading
- Five stocks we like better than Kering
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
- The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
Receive News & Ratings for Kering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kering and related companies with MarketBeat.com's FREE daily email newsletter.
